Case Report: Successful endoscopic full-thickness resection of an irregular submucosal tumor of the esophagus with surface focal white patches: horseshoe-shaped leiomyoma [0.03%]
内镜下全层切除不规则的食管黏膜下肿瘤（表面有局部白色斑块）一例：马蹄形平滑肌瘤
Lili Pan,Chuanfang Wang,Chong Zhang et al.
Lili Pan et al.
Esophageal leiomyoma is a rare benign tumor of the esophagus, accounting for approximately 1.2% of all esophageal tumors. Endoscopically, it typically appears as a protrusion into the esophageal lumen with intact and smooth mucosa, which ca...
Editorial: 150 years of laryngectomy: reviews on the state of the art and future perspectives [0.03%]
喉切除术150年：现状与未来展望综述编辑部观点
Dietmar Thurnher,Andreas Dietz,Cesare Piazza
Dietmar Thurnher
Dedifferentiated adamantinoma of long bones: a case report and literature review [0.03%]
长管状骨去分化腺瘤样癌的病例报告及文献复习
Xiaofei Xiu,Jiajia Li,Lisha Duan et al.
Xiaofei Xiu et al.
We present a rare case of dedifferentiated adamantinoma. The 48-year-old male patient was initially diagnosed with classic adamantinoma in the right fibula and underwent curettage. Two years postoperatively, the patient presented with progr...
Global burden of cancer in women, 1990-2021: a systematic analysis from the GBD 2021 study [0.03%]
1990年至2021年全球女性癌症负担：来自GBD 2021研究的系统分析
Yun Mao,Yebo Gao,Yongjie He et al.
Yun Mao et al.
Objective: This study evaluates global burden, disparities, and trends of female cancers (breast, cervical, uterine, ovarian) from 1990 to 2021, and identifies key contributing factors and intervention strategies. ...
Significant response to toripalimab plus axitinib for metastatic chromophobe renal cell carcinoma with sarcomatoid differentiation: a case report and literature review [0.03%]
托利伐单抗联合阿昔替尼治疗转移性嫌色肾细胞癌合并肉瘤样分化1例及文献复习
Xin Chen,Gonglin Tang,Weicheng Sun et al.
Xin Chen et al.
Chromophobe renal cell carcinoma (chRCC) is a rare subtype of renal cell carcinoma (RCC). Sarcomatoid differentiation is considered a result of dedifferentiation of the primary tumor. The coexistence of both components (chromophobe and sarc...
Synchronous papillary renal neoplasm with reverse polarity and multilocular cystic renal neoplasm of low malignant potential in unilateral kidney: case report with molecular analysis and literature review [0.03%]
单侧肾脏同步发生的具有逆向极性的乳头状肾细胞癌和低度恶性潜能的多房囊性肾肿瘤一例并文献复习
Pichayut Nithagon,Joeffrey Chahine,Lambros Stamatakis et al.
Pichayut Nithagon et al.
Papillary Renal Neoplasm with Reverse Polarity (PRNRP) is a rare renal tumor, recently described in 2019 by Al-Obaidy et al. defined by characteristic histology of papillary neoplasm with apically located WHO/ISUP grade 1nuclei and frequent...
Durable response to venetoclax, azacytidine, and ruxolitinib in chronic-phase myelofibrosis resistant to ruxolitinib: a case report and literature review [0.03%]
venetoclax、阿扎胞苷和鲁索利替尼治疗对鲁索利替尼耐药的慢性期骨髓纤维化获得持续反应：1例报告及文献复习
Xiaohong Liu,Xiujuan Zhang,Hongxia Shi
Xiaohong Liu
Myelofibrosis (MF) is a philadelphia chromosome-negative chronic myeloprolifera- tive neoplasm.It has a worse prognosis than polycythemia vera and essential thrombocy- themia.At present,both Chinese and foreign guidelines recommend ruxoliti...
KLF9 in cancer: a potential prognostic marker and therapeutic target [0.03%]
KLF9在癌症中的作用：一个潜在的预后标志物和治疗靶点
Xiaoxiao Xiao,Zhipeng Dai,Fang Liu et al.
Xiaoxiao Xiao et al.
Kruppel-like factor 9 (KLF9) is a transcription factor that has gained significant attention in recent years for its critical involvement in development and progression of various cancers. Recent research has revealed the dual nature in tum...
Analysis of risk factors for postoperative recurrence of stage IA lung adenocarcinoma [0.03%]
IA期肺腺癌术后复发危险因素分析
Wendong Xu,Runze Li,Dilihumaer Tuerxun et al.
Wendong Xu et al.
Objective: To explore the influencing recurrence in patients with stage IA lung adenocarcinoma following surgical resection. Method: A ...
Transcriptomic analysis on pancreatic adenocarcinoma patients uncovers KRAS-mediated PPAR pathway alteration [0.03%]
泛腺癌转录组分析发现KRAS介导的PPAR通路改变
Giuseppe Defazio,Federico Scolari,Sara Fancelli et al.
Giuseppe Defazio et al.
The incidence and mortality of pancreatic adenocarcinoma (PC) are expected to increase in the coming years, with survival rates remaining poor due to limited treatment options. KRAS mutations, present in over 70% of PC cases, drive aggressi...